Romiplostim
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05332 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 72 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 5 | Scott syndrome | KG + DL |
| 6 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 7 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 8 | platelet-type bleeding disorder | KG + DL |
| 9 | autosomal dominant macrothrombocytopenia | KG + DL |
| 10 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 11 | paroxysmal nocturnal hemoglobinuria | KG + DL |
| 12 | proteinuria | KG + DL |
| 13 | neurolymphomatosis | KG + DL |
| 14 | mixed-type autoimmune hemolytic anemia | KG + DL |
| 15 | drug-induced autoimmune hemolytic anemia | KG + DL |
| 16 | neonatal autoimmune hemolytic anemia | KG + DL |
| 17 | plasmacytoma | KG + DL |
| 18 | primary CD59 deficiency | KG + DL |
| 19 | Peyronie disease | KG + DL |
| 20 | cold agglutinin disease | KG + DL |
| 21 | neonatal thrombocytopenia | KG + DL |
| 22 | cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder | KG + DL |
| 23 | thrombotic thrombocytopenic purpura | KG + DL |
| 24 | TAFRO syndrome | KG + DL |
| 25 | seborrheic dermatitis | KG + DL |
| 26 | cyclic hematopoiesis | KG + DL |
| 27 | flood factor deficiency | KG + DL |
| 28 | inherited thrombophilia | KG + DL |
| 29 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 30 | familial thrombomodulin anomalies | KG + DL |
| 31 | methylcobalamin deficiency type cblG | KG + DL |
| 32 | Evans syndrome | KG + DL |
| 33 | penile fibromatosis | KG + DL |
| 34 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 35 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
| 36 | posterior leukoencephalopathy syndrome | KG + DL |
| 37 | infantile digital fibromatosis | KG + DL |
| 38 | X-linked severe congenital neutropenia | KG + DL |
| 39 | severe nonproliferative diabetic retinopathy | KG + DL |
| 40 | Ledderhose disease | KG + DL |
| 41 | dense granule disease | KG + DL |
| 42 | adult idiopathic neutropenia | KG + DL |
| 43 | carotid artery thrombosis | KG + DL |
| 44 | palmar fibromatosis | KG + DL |
| 45 | thrombocytopenia due to immune destruction | KG + DL |
| 46 | transient neonatal thrombocytopenia | KG + DL |
| 47 | papillomatosis | KG + DL |
| 48 | congenital factor V deficiency | KG + DL |
| 49 | papilloma | KG + DL |
| 50 | squamous papilloma | KG + DL |
(Showing top 50 of 72 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.